Patents by Inventor Noga Ron

Noga Ron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8716228
    Abstract: Use of a GPR54 agonist or antagonist for the treatment of a disease or disorder presenting behavioral abnormalities associated with impairment of sensory gating function, and/or for treatment of depression, and/or for improving cognitive function is disclosed. In particular, the invention relates to the use of kisspeptin or a peptide thereof for the treatment of schizophrenia.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: May 6, 2014
    Assignee: YEDA Research and Development Co. Ltd.
    Inventors: Michal Eisenbach-Schwartz, Gil M Lewitus, Michal Cardon-Yaakov, Noga Ron-Harel
  • Publication number: 20120135935
    Abstract: Use of a GPR54 agonist or antagonist for the treatment of a disease or disorder presenting behavioral abnormalities associated with impairment of sensory gating function, and/or for treatment of depression, and/or for improving cognitive function is disclosed.
    Type: Application
    Filed: May 27, 2010
    Publication date: May 31, 2012
    Inventors: Michal Eisenbach-Schwartz, Gil M. Lewitus, Michal Cardon-Yaakov, Noga Ron-Harel
  • Publication number: 20120135016
    Abstract: A method for inducing and enhancing neurogenesis and/or oligodendrogenesis from endogenous as well as from exogenously administered stem cells comprises administering to an individual in need thereof an agent selected from the group consisting of Copolymer 1, a Copolymer 1-related polypeptide, a Copolymer 1-related peptide, and activated T cells which have been activated by Copolymer 1, a Copolymer 1-related polypeptide, or a Copolymer 1-related peptide. The method is particularly useful for stem cell therapy in combination with the agent.
    Type: Application
    Filed: October 26, 2011
    Publication date: May 31, 2012
    Inventors: Michal Eisenbach-Schwartz, Ruth Arnon, Oleg Butovsky, Yaniv Ziv, Jonathan Kipnis, Noga Ron, Raya Eijam, Rina Aharoni
  • Publication number: 20090191173
    Abstract: A method for inducing and enhancing neurogenesis and/or oligodendrogenesis from endogenous as well as from exogenously administered stem cells comprises administering to an individual in need thereof an agent selected from the group consisting of Copolymer 1, a Copolymer 1-related polypeptide, a Copolymer 1-related peptide, and activated T cells which have been activated by Copolymer 1, a Copolymer 1-related polypeptide, or a Copolymer 1-related peptide. The method is particularly useful for stem cell therapy in combination with the agent.
    Type: Application
    Filed: November 29, 2005
    Publication date: July 30, 2009
    Inventors: Michal Eisenbach-Schwartz, Ruth Arnon, Oleg Butovsky, Yaniv Ziv, Jonathan Kipnis, Noga Ron, Raya Eilam, Rina Aharoni
  • Publication number: 20090010873
    Abstract: A method is provided for inducing and enhancing neurogenesis and/or oligodendrogenesis from endogenous as well as from exogenously administered stem cells, which comprises administering to an individual in need a neuroprotective agent such as a nervous system (NS)-specific antigen, a peptide derived therefrom, T cells activated therewith, poly-YE, microglia activated by IFN-? and/or IL-4 and combinations thereof. The method includes stem cell therapy in combination with the neuroprotective agent.
    Type: Application
    Filed: November 29, 2005
    Publication date: January 8, 2009
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Michal Eisenbach-Schwartz, Oleg Butovsky, Yaniv Ziv, Jonathan Kifnis, Noga Ron